Observational Data Analysis in EuroSIDA (MK-0518-058)

Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)

NCT00377065 ·Status: APPROVED_FOR_MARKETING

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

NCT00454337 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)

NCT01213316 ·Status: COMPLETED

Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment

NCT01346878 ·Status: COMPLETED

Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan

NCT01467349 ·Status: COMPLETED

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

NCT00219934 ·Status: COMPLETED

Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects

NCT00529243 ·Status: COMPLETED ·Phase: PHASE3

Effect of Dolutegravir Intensification on HIV-1 Reservoirs

NCT05351684 ·Status: COMPLETED ·Phase: PHASE2

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain

NCT00685191 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

NCT02218320 ·Status: COMPLETED

Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

NCT01533259 ·Status: COMPLETED ·Phase: PHASE3

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

NCT00807443 ·Status: COMPLETED ·Phase: PHASE2

Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events

NCT01417949 ·Status: COMPLETED ·Phase: PHASE4

Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy

NCT02611895 ·Status: COMPLETED ·Phase: NA

A Long-term Follow-up of the HIV-NAT Cohort

NCT00411983 ·Status: RECRUITING

Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation

NCT02383355 ·Status: COMPLETED ·Phase: PHASE4

Analytical Treatment Interruption in HIV Positive Patients

NCT02590354 ·Status: COMPLETED ·Phase: NA

"Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"

NCT05761509 ·Status: COMPLETED

Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen

NCT00738569 ·Status: COMPLETED ·Phase: NA

Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection

NCT01297127 ·Status: COMPLETED

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

NCT00562510 ·Status: TERMINATED ·Phase: PHASE3

Raltegravir as Early Therapy in African-Americans Living With HIV Study

NCT00667433 ·Status: COMPLETED ·Phase: PHASE1

Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy

NCT00887653 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

NCT05349838 ·Status: COMPLETED ·Phase: PHASE3

A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen

NCT00749580 ·Status: COMPLETED ·Phase: NA